taxes

Pharmalot By Ed Silverman

Once again, lawmakers introduce a bill to end tax breaks for consumer drug ads. Will it work this time?

Pharmalot By Ed Silverman

Pharmalittle: Will a small biotech upend the cholesterol market? J&J loses patent protection on key drug

Pharmalot By Ed Silverman

Pharmalittle: J&J loses a Remicade patent battle: NYC piles on and sues opioid makers

Pharmalot By Ed Silverman

Pharmalittle: Ohio rejects drug pricing proposal; another insurer tosses OxyContin

Pharmalot By Ed Silverman

IRS is urged to investigate Gilead for ‘dodging’ US taxes

Pharmalot By Ed Silverman

Pfizer spars with the taxman again, seeks $8 million in overdue interest

Pharmalot By Ed Silverman

Gilead avoided nearly $10 billion in taxes last year thanks to tax dodges

Pharmalot By Ed Silverman

After failed Allergan merger, Pfizer once again considers splitting up the company